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Introduction
Cushing’s syndrome (CS) or hyperadrenocorticism 
is one of the most frequent endocrinopathies in dogs 
whose prevalence and presentation coincide with the 
ones included in different authors’ reports (Gallelli et 
al., 2010; O’Neill et al., 2016; Carotenuto et al., 2019; 
Martins et al., 2019). In the present, and considering all 
different etiologies of the syndrome, it can be classified 
as adrenocorticotrophin (ACTH)-dependent Cushing’s 
syndrome and ACTH-independent or adrenal Cushing’s 
syndrome (Kooistra and Galac, 2012; Duan et al., 
2015). Within this last group, neoplastic causes (nodes, 
adenomas, and adrenal cortex carcinomas), bilateral 
nodular hyperplasia, and expression of receptors that are 
not normally found or expressed in the adrenal cortex, 
i.e., aberrant receptors, are considered (Vuorenoja et 
al., 2007; Bermichtein et al., 2008).
First references to the expression and functionality of 
the LH receptor (LHR) and, therefore, to the action of 
the luteinizing hormone (LH) over the adrenal cortex 
were found in postmenopausal women, in which it 
was observed that no longer after having experienced 
menopause, they developed the disease (Pabon et al., 
1996) with lack of existence of pituitary or suprarenal 
neoplasia or ACTH-producing neuroendocrine tumor. 
Lacroix et al. (2001), as well as other authors, argue 
that chronic stimulation of aberrant receptors causes 
bilateral adrenal hyperplasia to develop, afterward, 
nodes (uni- or bilateral), adenomas, and adrenal cortex 
carcinomas as last stage (Rilianawati et al., 1998; 
Mazzuco et al., 2006, 2007). In one in vitro study, 
Feelders et al. (2003) describe the changes taking place 
due to the LH chronic stimulation over its receptor and 
in the signaling of the hyperplastic adrenal cortex cells. 
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Abstract
Background: The expression and overexpression of luteinizing hormone (LH) receptors in the canine adrenal gland 
cortex have been reported. Therefore, it was hypothesized that a LH-dependent form of Cushing’s syndrome (CS) 
could exist in dogs. 
Aim: To assess whether the adrenal gland post-ovariectomy (OVx) exhibits a greater response to adrenocorticotrophin 
(ACTH) stimulation; to evaluate whether the adrenal gland responds to human chorionic gonadotropin (hCG) 
stimulation by increasing the release of cortisol; and to consider whether hCG stimulus testing would be useful as a 
diagnosis for possible cases of LH-dependent CS.
Methods: Cortisol concentrations were measured from healthy female dogs (n=16) at baseline and following ACTH 
stimulation before and 2 months after gonadectomy (OVx). Cortisol concentrations were also measured for female 
dogs with CS (n = 14) following administration of hCG (5000 IU). A post-hCG cortisol concentration greater than 140 
nmol/l was used to define dogs with LH-dependent Cushing’s syndrome.
Results: In normal female dogs, both pre- and post-stimulation cortisol concentrations increased following OVx (p = 
0.002 and p = 0.0003, respectively). In female dogs with CS, cortisol concentrations increased following stimulation 
with hCG in 57% (8/14; p = 0.002). Age at the time of OVx was associated (p = 0.015) with the cortisol response to 
hCG [8 (5–9) years vs. 3.5 (2–6) years, p = 0.0013).
Conclusion: Based on these results, an LH-dependent form of CS occurs in spayed female dogs, and that it is more 
likely to occur when female dogs are spayed later in life.
Keywords: Aberrant receptors, Cushing’s syndrome, Gonadectomy, hCG, Luteinizing hormone.
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In veterinary medicine, the first feasible case by an 
aberrant receptor in dogs was reported by Galac et al. 
(2008) due to adrenal cortex stimulation by gastric 
inhibitory peptide or glucose-dependent insulinotropic 
peptide. Later, Galac et al. (2010) described the 
presence of different aberrant receptors in the adrenal 
cortex in healthy dogs and dogs with CS, among them, 
the LHR ectopic overexpression. Moreover, as the 
responsible cause of endocrinopathy and adrenal tumor 
development, LH’s action has been confirmed in ferrets 
(Schoemaker et al., 2002, 2008).
Neutering by ovariectomy (OVx) in female dogs is 
increasingly common in early ages on account of birth 
control and prophylactic reasons (Root Kustritz, 2002). 
Nonetheless, there is great inequality among countries 
and regions within the same country regarding the age 
of OVx, depending on idiosyncrasy (Kubinyi et al., 
2009). In general, the age of OVx in South America 
tends to be higher than 2 or 3 years. Regarding CS 
and the proportion of spayed females, a range has 
been reported that covers from 61%, inferred from the 
study by Bennaim et al. (2018), similar to the 64.9% 
in Martins et al.’s (2019) study, to 86.1% pertaining 
to O’Neill et al.’s (2016) study. In retrospect, when 
analyzing medical records of dogs suffering from CS, 
it was striking that owners reported, in some cases, 
that they started noticing weight increase with changes 
in the shape of the abdomen and increasing liquid 
intake shortly after OVx.Since after OVx, the negative 
feedback of the gonadal axis is lost, and waiting for an 
increase in LH, the action of this hormone may be one 
of the causes of CS in female OVx dogs, which suggests 
LH-dependent CS. The objective was to evaluate, 
initially, whether cortisol concentrations are affected 
after OVx and, according to post-OVx assessment, 
carry out a second test. Such a test consisted of 
administering human chorionic gonadotropin hormone 
(hCG), given its similar LH effect in healthy dogs and 
dogs with CS (both OVx cases) to determine, firstly, 
whether it produces any effect over cortisol secretion 
and, secondly, whether it would be useful for the 





Sixteen normal weight, 3/5-body condition (WSAVA, 
2013), medium-size (weight: 13.4 ± 3.5 kg; age: 6.7 ± 
1.6 year) female dogs were referred for spaying from 
the Responsible Pet Ownership Program (12 mixed-
breed females and 4 beagles) after owners gave their 
consent to participate in the study. Laboratory and 
clinical examination and cardiorespiratory assessment 
were carried out a week before surgery to evaluate the 
animals’ good health conditions. By vaginal smear, it 
was confirmed that all of them were in anestrus. Two 
days before spaying, a synthetic ACTH stimulation test 
(tetracosactrin) was carried out (Synacthen 0.25 mg/ml 
®, Novartis Lab.), administering the complete ampoule 
(0.25 mg) intravenously (Frank et al., 2000). Basal and 
1-hour poststimulation cortisol evaluation times were 
considered. The same test was carried out 60 days after 
OVx (to avoid immediate postoperative stress and 




CS-OVx group: OVx dogs with presumptive CS 
diagnosis were selected based upon clinical signs (weight 
increase, more prominent abdomen, polyuria and 
polydipsia, and dermatological symptoms) and blood 
biochemistry alterations (hepatic enzymes increase and 
dyslipidemia) that were referred for final diagnosis and 
treatment. Age at consultation, age in which OVx was 
carried out, and time from OVx to CS final diagnosis 
were considered. An immediate abdominal ultrasound 
was carried out on female selected dogs, exploring 
adrenal glands, before carrying out diagnostic tests, to 
include only those which would be apt for the purpose 
of the study (apart from the hepatomegaly characteristic 
of CS, there was not supposed to be any other organic 
alteration). The inclusion criterion was that, by 
ultrasound, the adrenal gland (Liste et al., 1997) did not 
present tumor of irregular aspect and bigger than 2 cm, 
which may raise suspicions of an adrenal carcinoma. 
Only OVx dogs with increased bilateral gland or 
presence of node in one or both glands, of normal aspect 
and smaller than 2 cm, were admitted. The reason for not 
including animal with suspected adrenal carcinoma was 
that they might not express or overexpress receptors, 
both MC2R (for ACTH) and aberrant ones (LHR and 
GIPR), depending on the cell undifferentiating level 
(Weiss et al., 1989; Galac et al., 2010). After obtaining 
owners’ consent, 14 spayed females were selected for 
the study (10 medium-size mixed-breed, 1 Basenji, 1 
Fox Terrier, 1 Beagle, and 1 Poodle). The median age 
was 9.5 years (range 7–14) and weight 11.9 ± 3.3 kg. 
The median age in which OVx was carried out was 7 
(2–9) years, and the time between OVx and diagnosis 
was 3.5 (1–12) years. 
In order to confirm CS diagnosis, synthetic ACTH 
stimulus was carried out as previously described. 
Subsequently, suppression by dexamethasone was 
indicated by means of the cortisol/creatinine ratio in urine 
(Dexs/CCR) before and after administering 0.1 mg/kg 
of dexamethasone orally, every 8 hours (Galac et al., 
1997; Kooistra and Galac, 2012), considering a normal 
basal CCR value (pre-dexamethasone) up to 10 × 10–6 
and that inhibition occurs (pituitary origin indicator) 
when there is a decrease in the post-dexamethasone 
value of over 50% compared to the basal value.
It was possible to carry out a magnetic resonance 
imaging (MRI) of the seller region on 9 out of the 14 
selected females (owners of the remaining females did 
not give their consent on different grounds).
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hCG test
hCG dose preliminary analysis
For the preliminary study, 5000 IU of hCG (Gonacor 
5000, Ferring Lab.) were administered intramuscularly. 
First, doses indicated in reproduction were tested in 
three healthy OVx control female dogs (Kutzler, 2007); 
later, 2500 IU and, lastly, 5000  IU. Evaluated times 
were basal time (pre-hCG), 30 minutes, 1 hour, and 2 
hours after administration. It was only with 5000 IU that 
a slight increase was noted after 1 hour that reached its 
peak and did not differ with the measuring 2 hours, so 
it was decided to use this last dose in the development 
of the study and take into account the basal and 1 hour 
times (data not shown).
Control group (CG)
Six female dogs from the kennels of the institution 
(vivarium) were included. Such group comprised two 
mixed-breeds and four beagles (weight 12.3 ± 2 kg and 
age 7 ± 2 years), which had been OVx 60 days before 
the study due to management reasons of the vivarium. 
Once their health conditions were checked, the ACTH 
stimulation test was first carried out, and plasma 
ACTH was measured. Later (7 days), the 5000  IU-
hCG stimulation was carried out in a single-dose 
intramuscular administration (Gonacor 5000, Ferring 
Lab.), evaluating basal cortisol (pre-hCG) and 1 hour 
after administration.
CS-OVx group
5000  IU of hCG stimulation was carried out on the 
14 female dogs included in the study, as previously 
described. Stimulation was carried out the week after 
having carried out Dexs/CCR to ensure no inhibition 
of the adrenal axis due to exogenous corticosteroid. In 
accordance with the resulting hCG response (with or 
without considerable cortisol increase), dogs would 
be separated into two groups: CS-OVxA, with no 
significant increase, and CS-OVxB, significantly 
increasing.
Evaluated hormones
Cortisol was evaluated in plasma and urine (with 
the corresponding urinary creatinine) and the 
plasmatic ACTH (pACTH). Samples were obtained 
by venepuncture of the antebrachium cephalic vein. 
For cortisol, they were collected in plastic tubes 
with ethylenediaminetetraacetic acid anticoagulant. 
For pACTH, a separate refrigerated tube containing 
aprotinin was used; the sample was immediately 
centrifuged and frozen at –80  C until its processing. 
Only basal time was evaluated.
Cortisol was measured by the chemiluminescence 
method (Immulite 1000  ®, Siemens Healthineers, 
Munro, Argentina) with a 5.5%  interassay and 
8% intraassay coefficients of variation and a 5.5 nmol/l 
sensitivity.
Cortisol in urine was also evaluated by 
chemiluminescence, and creatinine was measured 
by laboratory routine automated method 
(MetrolabAutoanalyzer Merck, Darmstadt, Germany). 
Interassay and intraassay coefficients of variation were 
8% and 5%, respectively; sensitivity was 11 nmol/l for 
urinary cortisol and 1.77 µmol/l for urinary creatinine.
pACTH was also measured by chemiluminescence 
(Immulite 1000 ACTH: adrenocorticotropic hormone 
reagent 100 count 1/Bx, Siemens Healthineers, 
Munro, Argentina), being the interassay and intraassay 
coefficients of variation 8% and 7.6%, respectively, and 
sensitivity was 1.1 pmol/l. In our laboratory, reference 
intervals for such a method are 2.2–14.3 pmol/l.
Statistical analysis
The results of study 1 were compared by non-parametric 
paired sample test (Wilcoxon U test) between pre- and 
post-OVx cortisol values. 
In study 2, basal plasmatic cortisol and hCG 
poststimulation data were compared by the Wilcoxon 
U test (intragroup) and Mann–Whitney test (between 
groups). Primarily, it was evaluated whether there 
existed a substantial post-hCG cortisol increase in 
both groups and if there were differences between 
the CG and the 14 female dogs with CS-OVx. 
Afterward, the results obtained from the CS-OVxA 
and CS-OVxB groups were compared. Moreover, 
delta variation ∆
M-m
 between basal time (minimum 
value, m) and the highest post-hCG value obtained 
(maximum, M) was determined, as well as the 




Finally, a contingency table (Fisher’s exact test) 
was used to determine whether there is a statistical 
association between the age of OVx, the time elapsed 
between OVx, and diagnosis of CS and the response 
obtained to the hCG stimulus.
Data are expressed as median and percentiles 10 and 
90 (P10 and P90), being the significance level p < 0.05 
(GraphPad 6 software, San Diego, CA).
Ethical approval
The Committee for the Use and Care of Laboratory 
Animals (CICUAL) of the Faculty of Veterinary 
Sciences of the University of Buenos Aires approved 
all procedures (Protocol CICUAL #2013/17 and 
UBACyT 20720170100006BA), and written consent 
was obtained from all proprietors for carrying out all 
evaluations and their subsequent publication.
Results
Study 1
None of the female dogs included in the study presented 
alterations, neither in the pre-surgical exams (all of 
them were in the anestrus phase) nor 60 days after OVx.
After OVx, cortisol concentrations increased 
significantly (Fig. 1), in both basal value (p = 0.002) 
and 1-hour poststimulation (p = 0.0003). Basal cortisol 
was over the maximum cut-off limit in 6/16 (37.5 %). 
Poststimulation cortisol values exceeded 551.8 nmol/l 
in 4/16 (25%), similar to the hyperresponse that defines 
CS diagnosis (Gilor and Graves, 2011; Behrend et al., 
2013; Bennaim et al., 2019).
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Study 2
Imaging, ACTH stimulation, Dexs/CCR, and pACTH 
in female dogs of CG and with CS
Results of adrenal ultrasound and MRI (in cases in 
which it was carried out) and responses to diagnostic 
tests are shown in Table 1. Ultrasound tests indicated 
bilateral enlargement of adrenal glands. In two dogs 
(cases #6 year 9), one node in the left adrenal gland was 
also found, being, in each case, <1.5 cm. Via MRI (nine 
dogs), the presence of a hypophysis tumor could only 
be confirmed in four dogs; one of them reported the 
previously informed node as well (case #6).In CG, the 
ACTH stimulation test presented a normal response, 
basal cortisol being 122.6 (66.42–163.5) nmol/l, and 
1 hour 336.7 (252.4–389) nmol/l. The GC pACTH 
concentration was 6.5 (4.8–10.9) pmol/l. 
In dogs with CS, the ACTH stimulation study was 
hyperresponsive in 7/14 dogs (Table 1); cortisol value 
did not exceed 551.8 nmol/l after 1 hour in the rest 
of them (Fig. 2). Basal cortisol was 109 (62.9–218.8) 






Time of OVx 
diagnosis








 (MRI: 0.7 mm)
9 3 6 + + N
#2 M
 (MRI: 0.6 mm)
9 3 6 + + N
#3: Poodle 14 2 12 + + N
#4 M 11 6 5 + + N
#5 Basenji
 (MRI: 0.9 mm) 
7 2 5 + N N
#6 M**
 (MRI: 0.7 mm)




10 8 2 N N +
#8 M 9 7 2 N N +
#9 Fox T.**
 (MRI: n/v)
12 9 3 + N +
#10 Beagle
 MRI: n/v)
9 8 1 N N +
#11 M 13 9 4 N N +
#12 M
 (MRI: n/v)
12 9 3 N N +
#13 M 9 5 4 N N +
#14 M
 (MRI: n/v)
10 7 3 N N +
M = mixed-breed female dogs; Fox T. = Fox Terrier; MRI = magnetic resonance imaging; n/v = non-visible; **Dogs with nodes in adrenal gland; 
+ = Shows a higher response than the cut-off value 1-hour poststimulation or suppresses more than 50% post-dexamethasone administration; N = 
no hyperresponsive or no dexamethasone suppression. Poststimulation or suppression cut-off values are indicated.Age of diagnosis, age of OVx, 
and time elapsed between OVx and CS diagnosis are shown, as well as responses to ACTH tests, dexamethasone suppression/CCR and hCG test.
Fig. 1. Stimulation with ACTH before and after OVx. Note 
that after OVx, cortisol concentrations are higher. **p = 0.002 
between baseline cortisol values; ***p = 0.0003 between 
1-hour cortisol values. Median is indicated. Each circle 
corresponds to a studied dog. Delimited area corresponds to 
normal range of cortisol, pre- and post-ACTH stimulus.
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nmol/l, and 1 hour after ACTH was 544.9 (358.7–
938.1) nmol/l in the CS-OVx.
Dexs/CCR test (Table 1) suppressed more than 50% 
(60.5 [56–83]%) in 4/14 and it was less than 50 % (21 
[4–29]%) in 10/14 dogs. pACTH concentration was 
13.2 (2.7–17.8) pmol/l.
hCG stimulation test
There were no meaningful differences between pre-
and 1-hour post-hCG cortisol concentrations in the 
CG (Fig. 3). Basal cortisol and 1 hour post-hCG were 
lower compared to the CS-OVx group (p = 0.002 and 
p = 0.0004, respectively). Cortisol increased notably 
(p = 0.02) in dogs with CS-OVx after administering 
hCG (Fig. 3). This indicated that hCG stimulation with 
5000 IU acts differently in dogs with CS compared to 
control dogs. After observing the individual behavior 
of each dog after hCG, it was noted that in 6/14 there 
was no significant increase in cortisol, while there was 
in the remaining eight dogs (seven of these had no 
hyperresponse to the ACTH test and none had Dexs/
CCR inhibition)
Those in which there was no substantial cortisol increase 
1-hour post-hCG (basal: 105 [45.5–171.1]  nmol/l; 
1 hour: 97.4 [53.2–138]  nmol/l) were identified and 
grouped as CS-OVxA (n = 6). The remaining ones 
were grouped as CS-OVxB (n = 8), as they presented 
significant differences (p = 0.008) between pre- and 
1-hour post-hCG cortisol (92.3 [52.4–151.7]  nmol/l 
and 284.2 [157–767]  nmol/l, respectively) (Fig. 
3).Differences (p = 0.0007) between CS-OVxA and CS-
OVxB in cortisol concentration were evidenced only 
1-hour post-hCG (Fig. 3). There were no differences 
between the respective cortisol basal concentrations. 
Therefore, it was analyzed whether there would be 
differences between 1-hour post-hCG of CG versus 
CS-OVxA, not having found significant differences.
Considering the P90 of the CS-OVxA and CGs (138 
and 138.9 nmol/l, respectively) and the P10 of the CS-
OVxB group (157 nmol/l), there are no overlap cases 
observed. A post-hCG cut-off value of 140 nmol/l could 
Fig. 2. Stimulation with ACTH. (a) The response in all female 
dogs with CS-OVx (14); (b) separate responses of resulting 
CS-OVxA and CS-OVxB groups. It can be observed that 
not all stimulations (7/14) exceed the cut-off value of 551.8 
nmol/l after 1 hour. The delimited area corresponds to basal 
cortisol reference values.
Fig. 3. Cortisol concentration with 5000  IU of hCG 
stimulation test. (a) CG dogs and CS-OVx dogs (group of 14 
dogs); (b) resulting CS-OVxA and CS-OVxB groups. (a) No 
considerable changes were detected in the CG after 1 hour; 
cortisol level increased compared to its baseline value in CS-
OVx dogs (*p = 0.02). The basal cortisol concentration in 
this group was higher than in the GC (a–bp = 0.002). (b) **p = 
0.008; 1-hour cortisol versus baseline cortisol of CS-OVxB; 
a–bp = 0.0007; 1-hour cortisol of CS-OVxA versus 1-hour 
cortisol of CS-OVxB. There are no differences between basal 
cortisol concentrations of both groups. The delimited area 
corresponds to basal cortisol reference values.
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 of the hCG test 
were determined, being importantly higher (p = 0.0007) 
in CS-OVxB with regard to CS-OVxA and the CG. 
There were no differences between CG and CS-OVxA 





 (P90), the cut-off values could be set at 
values >30 for both estimators, as no bitch from the 




 that exceeded that value. 




 of the CS-OVxB group was 
92.7 and 92.3, respectively
pACTH concentrations were significantly higher (p = 
0.003) in CS-OVxA (12.8 [6.2–17.8] pmol/l) than in 
CS-OVxB (5.6 [2.7–6.6] pmol/l).
As shown in Table 1, dogs that reacted notably to hCG 
stimulus did not react to ACTH stimulus (except for one 
with both responsive tests, case #9). In none of them, 
there was dexamethasone suppression.Comparing 
cortisol concentrations when carrying out the ACTH 
stimulation test between CG versus CS-OVxa and 
CS-OVxB, no significant differences were observed 
between the basal cortisols of CG [122.6 (66.42–163.5) 
nmol/l] versus CS-OVxA (123.6 [74.5–218.8] nmol/l) 
and CS-OVxB (103.5 [62.9–151.7] nmol/l). At 1-hour 
post-ACTH, differences were found between the 
cortisol of CS-OVxA [751.8 (607–938.1) nmol/l] versus 
CG [336.7 (252.4–389) nmol/l] (p <0.001) and versus 
CS-OVxB (438.7 [358.7–648.4 nmol/l) (p < 0.01), with 
no differences between CG versus CS-OVxB.
On the other hand, pACTH did not show differences 
between CG [6.5 (4.8–10.2) pmol/l], CS-OVxB [5.6 
(2.7–6.6) pmol/l], and CS-OVxA [12.8 (6.2–17.8) 
pmol/l] (p < 0.01).
Age of diagnosis, age of OVx, and time between OVx 
and diagnosis
In CS-OVxA, age of diagnosis was 9 (7–14) years; age 
of OVx, 3.5 (2–6) years; time between OVx and CS 
diagnosis was 5.5 (5–12) years.
In CS-OVxB age of diagnosis was 10 (7–14) years; 
age of OVx, 8 (5–9) years; time between OVx and CS 
diagnosis was 3 (1–4) years.Age of diagnosis was the 
same in both groups (Fig. 5); there were differences in 
the age of OVx (p = 0.0013) and time between OVx 
and CS diagnosis (p = 0.0007).
Association between hCG-stimulation response and age 
of OVx
It was verified that there was a considerable statistical 
association (p = 0.009, OR: 0.03; 95%CI = 0.001–0.74) 
between the age of hCG stimulation and age of OVx (it 
Fig. 4. Comparison of cortisol at post-hCG time between the 
CGs, CS-OVxA, and CS-OVxB. It is expressed as median 
and 10th and 90th percentiles. The dotted line indicates the 
value of 140 nmol/l, with no overlap between the maximum 
values of CS-OVxA and the minimum values of CS-OVxB. 
(a–a) There are no significant differences; (a versus b) p = 
0.0007.
Fig. 5. Age of CS diagnosis, age of OVx, and time between 
OVx and CS diagnosis between CS-OVxA and CS-OVxB. 
There are differences only between age of OVx and time 
lapse and between OVx and CS diagnosis. Line indicates 
median age. **p = 0.0013 (CS-OVxA vs. CS-OVxB) and **p 






 values from hCG stimulation tests carried out on CG and 
dogs grouped in CS-OVxA and CS-OVxB.















Values are expressed as median and P10–P90.ap = 0.0007 versus CS-OVxA and versus CG. 
bp = 0.0007 versus CS-OVxA and versus CG. There are no differences between CS-OVxA 
and CG.
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was considered more than 7 year or less than that, as it 
was the median age of the 14 female dogs). 
Discussion
This study noted that basal cortisol level increased after 
OVx in healthy dogs (study 1) and presented greater 
ACTH stimulus-response. In study 2, control female 
dogs did not show cortisol increase after hCG stimulus. 
On the contrary, it was confirmed that when stimulating 
CS-OVx dogs with hCG, there was an increase in the 
hormone in some female dogs, while in others no 
increase was observed. Such response variation was 
related to the age in which OVx was carried out and the 
etiology of CS. Pessina et al. (2009) reported that 
there exist different responses to ACTH stimulus and 
low dose dexamethasone suppression, in both males 
and females. In such a study, it was observed that 
females have a greater response to exogenous ACTH 
than males. It was also observed that cortisol and ACTH 
concentrations vary during the estrous cycle (Gallelli et 
al., 2015), increasing during prestrus and estrus. Later, 
Gallelli et al. (2016) conveyed that both corticotropic 
cell and adrenal cortex cells of female dogs express 
estrogen receptors alpha, suggesting regulation of sex 
steroids of adrenal axis, as communicated in previously 
published studies (Handa and Weiser, 2014). In 
postmenopausal women, ferrets and mice, LHR 
overexpression in the adrenal cortex of individuals with 
CS was described as aberrant (Lacroix et al., 2001; 
Schoemaker et al., 2002, 2008). Therefore, LH increase 
occurring in postmenopausal women or by neutering in 
ferrets and mice is considered responsible for aberrant 
LHR activation. This results in hypercortisolism, 
changes in the adrenal morphology, and according to 
what was hypothesized by different authors, it could 
progress toward adrenal cortex carcinoma (Lacroix et 
al., 2001; Schoemaker et al., 2002, 2008). In human, 
LHRs implication in CS is only significant in a 
patient with adrenal (ACTH-independent) Cushing’s 
syndrome. Galac et al. (2010) describe for the first 
time the LHR overexpression in the adrenal cortex of 
healthy dogs, dogs with adenoma, and adrenal cortex 
carcinoma, being located in zona glomerulosa and zona 
fasciculata.
This would explain cortisol increase after OVx (it was 
confirmed that the ovary had been completely removed) 
in the first study. However, within reference ranges, it 
is still higher than the level before OVx. In women, 
cortisol increase is also described during climacteric 
and postmenopause, and that replacement with estradiol 
mitigates adverse effects of such hormone (Woods et 
al., 2006; Cagnacci et al., 2011; Ycaza Herrera et al., 
2017) and inhibits steroidogenesis in ovariectomized 
rats (Jopeck et al., 2018). Postmenopausal or post-
OVx estradiol decrease could be related to adrenal 
axis deregulation. On the other hand, gonadal axis 
inhibition is lost, resulting in an LH increase observed 
after spaying in postpubertal females (Löfstedt and 
Van Leeuwen, 2002; Buijtels et al., 2006). Therefore, 
cortisol increase in this group of dogs may be attributed 
to the combined effect of estradiol decrease and LH 
increase. After stimulation with ACTH, the greatest 
increase in cortisol observed, even above its cut-off 
values in some bitches, could be that a synergistic 
action between LH and ACTH occurs in cells of the 
fasciculata zone. Surgical stress cannot be considered a 
reason for this due to the time elapsed; even the >551.8 
nmol/l response in one dog is striking. While this could 
result from consultation stress, a greater sensitivity was 
still evidenced in the cells of zona fasciculata when 
exposed to ACTH stimulus. Unfortunately, apart from 
arranged monitoring, follow-up examination could be 
carried out, neither in this dog nor in the rest of the 
group.
The result of the 5000  IU-hCG study in dogs of the 
CG recently spayed produced no stimulation after 
hCG. This is in contrast with the CS group, in which 
it was confirmed that eight dogs showed considerable 
stimulation. Moreover, age of OVx and time elapsed 
until carrying out the study would play a major role, as 
healthy dogs from the vivarium were 2 years younger 
on average than dogs with CS, and post-OVx time in 
which the test was carried out was 60 days for the first 
group, whereas for the CS-OVx group, it was of at least 
3.5 years. As later discussed, this is important, as there 
is a longer action time of LH over the adrenal gland. 
Considering the CS-OVx population, it can be clearly 
observed that there is a difference in hCG responses 
related to the age of OVx and time elapsed between 
OVx and diagnosis of the disease. Regarding neutering 
and CS, reports informed that most female dogs with 
CS were spayed (O’Neill et al., 2016; Bennaim et 
al., 2018; Martins et al., 2019), but none of such 
reports indicates the spaying age and its relationship 
through time (early or late) with the presence of the 
symptoms of the disease. The age in which dogs were 
spayed seems to be important, and it may, somehow, 
resemble what Schoemaker et al. (2000) described in 
ferrets. Spayed age (8 years, between 5 and 9) in dogs 
that reacted to hCG stimulus and that are potentially 
considered LH-dependent CS was 5 years later than 
those that did not react significantly to hCG stimulation 
(younger spaying: 3.5 year, between 2 and 6). It is 
significant that the time-lapse between OVx and CS 
diagnosed in dogs that reacted to hCG stimulus was 
3 year (between 1 and 3), while in the other group, it 
was 5.5 year (between 5 and 12). This could be related 
to a longer time of action of both estrogens and LH 
(with their variations depending on the estrous cycle) 
over the adrenal cortex, being able to cause changes 
and the overexpression of LHR in rats as postulated 
by Apaja et al. (2005). By being spayed at an earlier 
time, and given the possible estradiol and LH effect 
over its receptor in the adrenal cortex (Gallelli et al., 
2016), the action of this hormone would not be present, 
and LH by itself would not be enough to produce LHR 
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overexpression and functionality. This hypothesis 
requires further investigation. Late neutering could 
be compared to menopause in women and later CS 
development by LH (Pabon et al., 1996; Lacroix et 
al., 1999, 2001). The question would be: why would 
there be such a difference among OVx dogs? In other 
words, why is it possible for LHR to be overexpressed 
and functional, resulting in CS in some cases but not in 
others? A possible explanation could be that in the first 
place, as stated before, it must be considered a longer 
time estradiol action and its steroidogenesis regulatory 
effect over the adrenal cortex in the group in which a 
later OVx was carried out (Jopeck et al., 2018). The 
second aspect is the LH role. It has been described 
that maturity and LHR expression in rats is a process 
physiologically controlled by gonadotrophins (Apaja et 
al., 2005). Moreover, Kero et al. (2000) describe that 
LH increase induces the expression of its receptor and 
steroidogenesis in the adrenal cortex, depending on 
the LHR expression level, according to what Jopeck et 
al. (2018) observed in rats. Meij et al. (1997) report 
substantially higher LH concentrations in neutered 
dogs with CS than in unneutered dogs, as it would 
be reasonable to expect high LH concentration in the 
female dogs included in this study. Thus, the post-OVx 
LH increase (carried out in a later stage) may cause the 
LHR expression in the adrenal cortex of the female 
dog (with a longer exposure time in years to increases 
in estrogen during the estrous cycle), resembling that 
described in postmenopausal women, ferrets, and mice 
(Lacroix et al., 2001; Apaja et al., 2005; Christopoulos 
et al., 2005; Schoemaker et al., 2008). It would then 
be possible that in younger castrated bitches the origin 
of Cushing’s syndrome is mainly pituitary-dependent, 
while if they are castrated at an older age, the probability 
of being of adrenal origin increases, particularly if it is 
an adrenal cortex tumor and if the RLH has or does not 
have implications in its development, something that 
should be investigated in the dog. In reference to the 
reaction to CS diagnostic tests, pACTH concentrations 
and hCG test, it was significant that dogs that reacted 
to hCG were those whose ACTH stimulation reflected 
<551.8 nmol/l (and without significant differences 
with the CG) were not suppressed by dexamethasone 
and presented lower pACTH concentrations so that the 
cause for this condition should be considered ACTH 
non-dependent in this group of dogs. In these cases, LH 
is likely to be considered the cause of hypercortisolism 
instead of native ACTH. The resulting hypercortisolism 
causes corticotropic cell inhibition (lower pACTH), 
which causes dexamethasone not to act as an inhibitor 
of the adrenal axis, as the glucocorticoid receptor 
is already blocked decreased (Bosje et al., 2002; 
Kooistra and Galac, 2012). Should the diagnostic 
sensitivities described for ACTH stimulation test and 
dexamethasone suppression (Kooistra et al., 1997; 
Behrend and Kemppainen, 2001; Behrend et al., 2013; 
Bennaim et al., 2018, 2019) be considered, many of 
the false-negative cases for the ACTH stimulation, or 
there was no cortisol suppression by dexamethasone 
due to inhibition of the adrenal axis, could be LH-
dependent CS. According to the test and its results, they 
are considered possible adrenal carcinoma, pituitary 
macroadenoma, erratic behavior, stress, and even the 
concurrent presence of pituitary and adrenal adenoma 
(van Bokhorst et al., 2018).
It is feasible that in OVx female dogs, hypercortisolism 
is the result of the native ACTH action and that LH 
may play a combined stimulatory role. The behavior 
observed in dogs of experience 1 and case # 9, which 
presented a hyperresponsive in both stimulation tests, 
could indicate what was previously mentioned. 
hCG stimulation proved to be useful to identify females 
with possible LH-dependent CS, given the observed 
cortisol increase. Indication and interpretation of such 
stimulation should be carried out only in dogs with ACTH 
non-dependent CS, together with the results of the ACTH 
stimulation, dexamethasone suppression (regardless of 
the method), and the pACTH concentrations. If the 
response to ACTH stimulus is <551.8 nmol/l and, there 
is no dexamethasone suppression alongside a decreased 
pACTH concentration, the possibility of being LH-
dependent is viable. In turn, the prospect of an adrenal 
tumor suspected of carcinoma or a macroadenoma in 
the pituitary must have been dismissed by imaging. This 
is important since it opens the therapeutic possibility 
with GnRH agonists or antagonists as in ferrets or as 
suggested in humans (Lacroix et al., 1999; Wagner et 
al., 2001, 2005). At the time of reporting our findings, 
two bitches had been treated for 6 months with a GnRH 
agonist, obtaining encouraging results (disappearance 
of clinical signs, normalization of CRC and ACTH, and 
hCG and ACTH stimulations). Another two dogs are 
with the same treatment, and we await their conclusion 
to analyze the results and communicate them.
Diagnostic sensitivity of the test to discriminate 
possible LH-dependent CS from those does not make 
this a useful test to diagnose this specific group. The 
study requires the evaluation of more cases and deeper 
investigation regarding their molecular aspects. A 
considerable number of OVx dogs were dismissed, as 
only dogs whose owners agreed to be part of the study 
were included. This would explain that the number of 
females with and without response to hCG is almost 
the same. It is not possible to state the real incidence of 
LH-dependent CS until the further performance of this 
test on new cases on a routine basis.On the other hand, 
for ethical reasons, it was not possible to collect adrenal 
glands or nodes samples to analyze LHR expression and 
functionality, being able to compare, in this way, the 
hCG-responding ones to the hCG non-responding ones 
and, consequently, proving or discarding the previously 
stated hypothesis. Therefore, it could only be inferred 
that it would be overexpressed and functional in a group 
of OVx dogs, based on the response when stimulated 
with hCG and what was reported by Galac et al. (2010). 
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Including females with possible adrenal carcinoma and 
males in the study is also pending. 
Conclusion
In conclusion, we observed an increase in cortisol post 
OVx. Spaying age and time elapsed between OVx and 
the presence of CS clinical signs and its diagnosis are 
important data to be considered, together with the results 
of ACTH stimulation, dexamethasone suppression and 
the pACTH concentration. Normally, patient with 
pituitary-dependent CS didn’t have a response to hCG 
given that their CS is due to excessive stimulation of 
their adrenal by their excessive endogenous ACTH
Diagnostic imaging (pituitary and adrenal glands) will 
help in the diagnostic orientation toward the possibility 
of LH-dependent CS. Finally, hCG stimulation would 
be useful for the distinction of possible LH-dependent 
CS cases. Therefore, it would be the last step after 
dismissing other causes, as previously discussed. 
Values to be considered are 1-hour post-hCG cortisol 
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